Neeman & Industry News
DCGI to implement e-Gov in its working The Drugs Controller General of India (DCGI) to have a single window facility for drug approval soon...
India’s nutrition boom produces contract research boon As the need for scientific support for potential health claims for healthy foods increases, India is leveraging its pharmaceutical expertise to take a bite of the functional foods pie. ...
New Indian Regulatory Guidance by Central Drugs Standard Control Organization Guidance for Industry on Submission of Clinical Trial Application for Evaluating Safety and Efficacy - Central Drugs Standard Control Organization...
Indian Clinical Data Management market is expected to ramp up to $150 million MNCs are more than willing to outsource their needs to India because of it\'s technological innovation, creditable quality, operational flexibility, cost effectiveness, time-to-market and competitive advantage according to Koteshwar Govind, Deputy Manager,...
India: Attractive Market for Biopharmaceutical Companies Looking to Accelerate Their Clinical Trials The Clinical Research Market in India is growing at a very rapid rate according to anyone’s statistics…It is exploding according to all the hype. ...

Neeman News

 
  CTRI Confirms Leading Indian CRO Supports Majority of Hemophilia Trials in India  
  Max Neeman International is the only CRO in India to manage hemophilia trials according to the Clinical Trials Registry-India (CTRI). Of the total hem....  
     
  Max Neeman International ISO 14155: 2011 Certified for Medical Device Trials  
  Max Neeman announces the grant of ISO 14155:2011 certificate; the only Indian CRO and one of only a few global CROs to be certified for design, conduc....  
     
  Max Neeman International Completes Targeted Enrollment of 15,000 for Large Ph IV Study  
  RESEARCH TRIANGLE PARK, N.C., April 12, 2011 /PRNewswire/ -- Max Neeman meets enrollment and timeline of 15,000 for a large, Phase IV metabolic disord....  
     
  Max Neeman International Responds to New India Clinical Research Guidelines  
  RESEARCH TRIANGLE PARK, N.C., May 3, 2011 /PRNewswire/ -- The Drug Controller General of India (DCGI) has formed new Regulatory and ICH GCP guidelines....  
     
  Max Neeman International Launches Customized Project Management Software for India-based Clinical Studies  
  Max Neeman International, creates and launches customized Project Management Software (PMS) to meet unique study needs and client demands.....  
     

 2 3 4 5 Next